BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37365684)

  • 1. Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53.
    Kabir M; Sun N; Hu X; Martin TC; Yi J; Zhong Y; Xiong Y; Kaniskan HÜ; Gu W; Parsons R; Jin J
    J Am Chem Soc; 2023 Jul; 145(27):14932-14944. PubMed ID: 37365684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone acetyltransferase promotes fluoride toxicity in LS8 cells.
    Deng H; Fujiwara N; Cui H; Whitford GM; Bartlett JD; Suzuki M
    Chemosphere; 2020 May; 247():125825. PubMed ID: 31927229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.
    Collins HM; Abdelghany MK; Messmer M; Yue B; Deeves SE; Kindle KB; Mantelingu K; Aslam A; Winkler GS; Kundu TK; Heery DM
    BMC Cancer; 2013 Jan; 13():37. PubMed ID: 23356739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53.
    Ai G; Dachineni R; Kumar DR; Marimuthu S; Alfonso LF; Bhat GJ
    Tumour Biol; 2016 May; 37(5):6007-16. PubMed ID: 26596838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Id4 dependent acetylation restores mutant-p53 transcriptional activity.
    Knowell AE; Patel D; Morton DJ; Sharma P; Glymph S; Chaudhary J
    Mol Cancer; 2013 Dec; 12():161. PubMed ID: 24330748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53.
    Sykes SM; Stanek TJ; Frank A; Murphy ME; McMahon SB
    J Biol Chem; 2009 Jul; 284(30):20197-205. PubMed ID: 19494119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin rescue p53Y220C in BxPC-3 pancreatic adenocarcinomas cell line: Evidence-based on computational, biophysical, and in vivo studies.
    Malhotra L; Goyal HKV; Jhuria S; Dev K; Kumar S; Kumar M; Kaur P; Ethayathulla AS
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129807. PubMed ID: 33278547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 Oligomerization is essential for its C-terminal lysine acetylation.
    Itahana Y; Ke H; Zhang Y
    J Biol Chem; 2009 Feb; 284(8):5158-64. PubMed ID: 19106109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain.
    Mellert H; Sykes SM; Murphy ME; McMahon SB
    Cell Cycle; 2007 Jun; 6(11):1304-6. PubMed ID: 17534149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
    Liu L; Scolnick DM; Trievel RC; Zhang HB; Marmorstein R; Halazonetis TD; Berger SL
    Mol Cell Biol; 1999 Feb; 19(2):1202-9. PubMed ID: 9891054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.
    Dornan D; Shimizu H; Burch L; Smith AJ; Hupp TR
    Mol Cell Biol; 2003 Dec; 23(23):8846-61. PubMed ID: 14612423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
    Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
    BMC Mol Biol; 2012 Jun; 13():20. PubMed ID: 22731250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
    Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
    Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
    Oh ET; Park MT; Choi BH; Ro S; Choi EK; Jeong SY; Park HJ
    Invest New Drugs; 2012 Apr; 30(2):435-42. PubMed ID: 20978925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer.
    Malhotra L; Sharma S; Hariprasad G; Dhingra R; Mishra V; Sharma RS; Kaur P; Ethayathulla AS
    Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119343. PubMed ID: 36007676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3.
    Vincek AS; Patel J; Jaganathan A; Green A; Pierre-Louis V; Arora V; Rehmann J; Mezei M; Zhou MM; Ohlmeyer M; Mujtaba S
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30072621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage.
    Magni M; Buscemi G; Maita L; Peng L; Chan SY; Montecucco A; Delia D; Zannini L
    Cell Death Differ; 2019 May; 26(5):918-931. PubMed ID: 30050056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tetramerisation on site-specific post-translational modifications of p53: comparison of human and murine p53 tumor suppressor protein.
    Warnock LJ; Knox A; Mee TR; Raines SA; Milner J
    Cancer Biol Ther; 2008 Sep; 7(9):1481-9. PubMed ID: 18769132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.